EGM
VRDN icon

Engineers Gate Manager’s Viridian Therapeutics VRDN Stock Holding History

Engineers Gate Manager’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,979
Closed -$1.28M – 2597
2025
Q4 		$1.28M Buy
+40,979
New +$1.12M 0.02% 918
2025
Q3 		– Sell
-16,504
Closed -$231K – 2574
2025
Q2 		$231K Sell
16,504
-3,127
-16% -$42.4K ﹤0.01% 1845
2025
Q1 		$265K Buy
+19,631
New +$334K ﹤0.01% 1772
2024
Q4 		– Sell
-13,987
Closed -$318K – 2605
2024
Q3 		$318K Buy
+13,987
New +$229K 0.01% 1594
2023
Q4 		– Sell
-16,495
Closed -$253K – 2286
2023
Q3 		$253K Buy
+16,495
New +$315K 0.01% 1400
2023
Q2 		– Sell
-20,972
Closed -$534K – 2061
2023
Q1 		$534K Buy
20,972
+12,836
+158% +$412K 0.02% 942
2022
Q4 		$238K Buy
+8,136
New +$187K 0.01% 1299
2019
Q2 		– Sell
-2,020
Closed -$85K – 1393
2019
Q1 		$85K Buy
2,020
+281
+16% +$12.7K 0.01% 883
2018
Q4 		$79K Buy
1,739
+355
+26% +$20.5K 0.01% 823
2018
Q3 		$116K Buy
1,384
+280
+25% +$26.4K 0.01% 851
2018
Q2 		$106K Buy
+1,104
New +$117K 0.01% 918

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Engineers Gate Manager's VRDN Position: Q1 2026 in Review

Engineers Gate Manager sold out of Viridian Therapeutics (VRDN) in Q1 2026, closing a stake of 40,979 shares — an estimated $1.28M sold.

Engineers Gate Manager first reported a position in VRDN in Q2 2018 and held it in 11 quarters. The position peaked at $1.28M in Q4 2025. 225 funds tracked by Wall St. Rank hold VRDN as of Q1 2026.

  • Engineers Gate Manager reported no remaining Viridian Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 40,979 Viridian Therapeutics shares in Q1 2026, an estimated $1.28M.
  • Engineers Gate Manager first reported a position in Viridian Therapeutics in Q2 2018 and held it in 11 quarters.
  • Engineers Gate Manager's Viridian Therapeutics position peaked at $1.28M in Q4 2025.
  • 225 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.